GDF2026 - Office of Pharmaceutical Quality (OPQ) Keynote
Food and Drug Administration (public forum) · July 30, 2026
An FDA presenter reviewed Office of Pharmaceutical Quality and Office of Generic Drugs initiatives, outlining the new PreCheck program, nitrosamine mitigation efforts, the Quality Management Maturity assessments, use of AI and CASA in reviews, and CDER research supporting generic drug access and cost savings.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.